A Clinical Study on the Efficacy and Safety of Zeprumetostat in Relapsed/Refractory Large Granular Lymphocyte Leukemia

NCT07692529 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Large Granular Lymphocyte Leukemia
T-LGL Leukemia

Interventions

DRUG: zeprumetostat

Sponsor

Institute of Hematology & Blood Diseases Hospital, China